Correlation Between Karyopharm Therapeutics and 23Andme Holding
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and 23Andme Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and 23Andme Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and 23Andme Holding Co, you can compare the effects of market volatilities on Karyopharm Therapeutics and 23Andme Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of 23Andme Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and 23Andme Holding.
Diversification Opportunities for Karyopharm Therapeutics and 23Andme Holding
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Karyopharm and 23Andme is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and 23Andme Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 23Andme Holding and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with 23Andme Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 23Andme Holding has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and 23Andme Holding go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and 23Andme Holding
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 2.23 times less return on investment than 23Andme Holding. In addition to that, Karyopharm Therapeutics is 1.8 times more volatile than 23Andme Holding Co. It trades about 0.05 of its total potential returns per unit of risk. 23Andme Holding Co is currently generating about 0.21 per unit of volatility. If you would invest 335.00 in 23Andme Holding Co on October 14, 2024 and sell it today you would earn a total of 49.00 from holding 23Andme Holding Co or generate 14.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Karyopharm Therapeutics vs. 23Andme Holding Co
Performance |
| Timeline |
| Karyopharm Therapeutics |
| 23Andme Holding |
Karyopharm Therapeutics and 23Andme Holding Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karyopharm Therapeutics and 23Andme Holding
The main advantage of trading using opposite Karyopharm Therapeutics and 23Andme Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, 23Andme Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23Andme Holding will offset losses from the drop in 23Andme Holding's long position.| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |